文献速递主动脉疾病

EVAR与OAR术后主动脉十二指肠瘘的对比分析

Aortoduodenal fistulas after endovascular abdominal aortic aneurysm repair and open aortic repair.
PubMed 文献 · J Vasc Surg · 2021-03-05

本研究回顾性分析了2015年1月至2020年5月收治的24例主动脉十二指肠瘘(ADF)患者,其中EVAR术后9例、OAR术后15例,占同期腹主动脉瘤修复术的约4.3%。

要点

  • EVAR与OAR术后ADF患者总体生存有限,两组术后死亡率无显著差异。
  • 血培养最常见为大肠埃希菌(25%),腹腔涂片以念珠菌属为主(61%)。

核心结论

  • EVAR或OAR术后发生的ADF患者总体生存有限,两种术后ADF在术后死亡率上无显著差异,但ADF-OAR组总体术后并发症发生率似乎更高。

研究设计与样本

  • 回顾性分析2015年1月至2020年5月单中心收治的24例ADF患者(男20例;中位年龄69岁,范围53-82岁),其中EVAR术后9例、OAR术后15例,占同期腹主动脉瘤修复术的约4.3%。

主要发现

  • 从初次主动脉修复至ADF诊断的中位间隔:ADF-EVAR组68个月(范围6-83个月),ADF-OAR组80个月(范围1-479个月)。
  • ADF-EVAR组3例因手术高风险拒绝手术,ADF-OAR组1例移除主动脉假体未重建;其余20例中12例行原位主动脉置换,8例行解剖外重建加主动脉结扎。
  • 平均随访26个月,无早期肢体丧失,但发生静脉移植物破裂(ADF-EVAR)1例、主动脉残端破裂(ADF-OAR)1例、同种移植物相关输尿管动脉瘘(ADF-OAR)1例。
  • 血培养最常见为大肠埃希菌(25%患者),腹腔涂片以念珠菌属为主(61%);ADF-EVAR组和ADF-OAR组院内死亡率分别为22%和13%,1年死亡率分别为22%和33%。

临床怎么用

  • 对于EVAR或OAR术后出现ADF的患者,应认识到其总体生存有限,需个体化评估手术风险与治疗方案。
  • ADF-OAR患者术后并发症发生率较高,围手术期应加强并发症监测与管理。
  • 血培养大肠埃希菌和腹腔念珠菌属常见,抗感染方案应覆盖相应病原体。

局限性

  • 本研究为单中心回顾性分析,样本量小(24例),可能存在选择偏倚和信息偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In the present study, we have reported and compared aortoduodenal fistulas (ADFs) after endovascular abdominal aortic aneurysm repair (EVAR) vs after open aortic repair (OAR). METHODS: We retrospectively analyzed the data from patients treated for ADFs from January 2015 to May 2020 in our hospital. The clinical data, diagnostic procedures, and surgical options were evaluated. The primary endpoints of the present study were 30-day and 1-year mortality. The secondary endpoints were major postoperative complications. RESULTS: A total of 24 patients (20 men; median age, 69 years; range, 53-82 years) were admitted with ADFs after EVAR (n = 9) or OAR (n = 15). These patients accounted for ∼4.3% of all abdominal aortic aneurysm repairs in our hospital. The median interval from the initial aortic repair and the diagnosis of ADF was 68 months (range, 6-83 months) for the ADF-EVAR group and 80 months (range, 1-479 months) for the ADF-OAR group. Three patients in the ADF-EVAR group had refused surgical treatment owing to their high surgical risk. One patient in the ADF-OAR group had undergone removal of the aortic prosthesis without replacement. Of the remaining 20 patients, 12 (ADF-EVAR group, n = 4; ADF-OAR group, n = 8) had undergone in situ replacement of the aorta and 8 (ADF-EVAR group, n = 2; ADF-OAR group, n = 6) had undergone extra-anatomic reconstruction with aortic ligation. After a mean follow-up of 26 months, no patient had experienced early limb loss. However, one case of rupture of the venous graft (ADF-EVAR), one case of aortic stump blowout (ADF-OAR), and one case of a ureteroarterial fistula with a homograft (ADF-OAR) had occurred. Overall, the incidence of postoperative complications was significantly greater after ADF-OAR (93% vs 33%; P = .036). The most frequent bacteria involved in the blood cultures were Escherichia coli (25% of patients), and Candida spp. (61%) were the predominant pathogens found on intra-abdominal smears. The in-hospital mortality rates for the ADF-EVAR and ADF-OAR group were 22% and 13%, respectively. The corresponding 1 -year mortality rates were 22% and 33%. CONCLUSIONS: Patients with ADFs after EVAR or OAR have limited overall survival. In addition to the similar therapeutic approaches, we found no significant differences in postoperative mortality between these two uncommon pathologic entities. In our study, the overall postoperative morbidity seemed greater for the ADF-OAR group.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Omran S, Raude B, Bürger M, et al. Aortoduodenal fistulas after endovascular abdominal aortic aneurysm repair and open aortic repair. J Vasc Surg. 2021. PMID: 33684467. doi:10.1016/j.jvs.2021.02.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。